BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18283733)

  • 1. [Efficacy of production of reassortant of epidemic strains and cold-adapted influenza viruses in chicken embryo and MDCK cells].
    Kiseleva IV; Isakova IN; Larionova NV; Oleĭnik ES; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):40-5. PubMed ID: 18283733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leading role of genes coding polymerase complex in attenuation of domestic donor viruses for A and B live influenza vaccine].
    Kiseleva IV; Larionova NV; Voeten JT; Teley LC; Drieszen-van der Cruijsen SK; Heldens JG; van den Bosch JF; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):41-7. PubMed ID: 21381376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.
    Kiseleva I; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rudenko L; Shaw AR; Youil R
    J Virol Methods; 2004 Mar; 116(1):71-8. PubMed ID: 14715309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
    Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Live influenza vaccine: laboratory markers of attenuation].
    Isakova IN; Kiseleva IV; Larionova NV; Oleĭnik ES; Rudenko LG
    Vopr Virusol; 2007; 52(4):22-6. PubMed ID: 17722606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Zhang W; Xue T; Wu X; Zhang P; Zhao G; Peng D; Hu S; Wang X; Liu X; Liu W; Liu X
    Vaccine; 2011 Oct; 29(45):8032-41. PubMed ID: 21864614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Live cold-adapted influenza vaccine: state-of-the-art].
    Gendon IuZ
    Vopr Virusol; 2011; 56(1):4-17. PubMed ID: 21427948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restriction analysis of genome composition of live influenza vaccine].
    Kiseleva IV; Larionova NV; Teley LC; Rudenko LG
    Vopr Virusol; 2011; 56(3):28-32. PubMed ID: 21786624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.
    Krutikova EV; Stepanova EA; Wong PF; Kiseleva IV; Grigor'eva EP; Rudenko LG
    Bull Exp Biol Med; 2020 Mar; 168(5):669-672. PubMed ID: 32248454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions.
    Le J; Orff EJ; Fulvini AA; Huang L; Onodera S; Pokorny BA; Malewicz A; Primakov P; Bucher DJ
    Vaccine; 2015 Feb; 33(7):879-84. PubMed ID: 25545595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse genetic platform for inactivated and live-attenuated influenza vaccine.
    Jung EJ; Lee KH; Seong BL
    Exp Mol Med; 2010 Feb; 42(2):116-21. PubMed ID: 20054235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].
    Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses?
    Subbarao K; Webster RG; Kawaoka Y; Murphy BR
    Virus Res; 1995 Dec; 39(2-3):105-18. PubMed ID: 8837878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.
    Ghendon YZ; Markushin SG; Akopova II; Koptiaeva IB; Nechaeva EA; Mazurkova LA; Radaeva IF; Kolokoltseva TD
    Vaccine; 2005 Sep; 23(38):4678-84. PubMed ID: 16026905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
    Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.